KIT
Summary: This gene encodes the human homolog of the proto-oncogene c-kit. C-kit was first identified as the cellular homolog of the feline sarcoma viral oncogene v-kit. This protein is a type 3 transmembrane receptor for MGF (mast cell growth factor, also known as stem cell factor). Mutations in this gene are associated with gastrointestinal stromal tumors, mast cell disease, acute myelogenous lukemia, and piebaldism. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008].
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
KIT proto-oncogene receptor tyrosine kinase | MIM:164920 | Ensembl:ENSG00000157404 | HGNC:HGNC:6342 | PA30128 | 4q12 |
GO terms in KIT
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
BP | TAS | GO:0000165 | MAPK cascade |
BP | IDA | GO:0000187 | activation of MAPK activity |
BP | ISS | GO:0001541 | ovarian follicle development |
BP | IEA | GO:0002318 | myeloid progenitor cell differentiation |
BP | IEA | GO:0002320 | lymphoid progenitor cell differentiation |
BP | ISS | GO:0002327 | immature B cell differentiation |
BP | ISS | GO:0002371 | dendritic cell cytokine production |
BP | IDA | GO:0002551 | mast cell chemotaxis |
BP | TAS | GO:0006357 | regulation of transcription by RNA polymerase II |
BP | IEA | GO:0006687 | glycosphingolipid metabolic process |
BP | ISS | GO:0006954 | inflammatory response |
BP | TAS | GO:0007165 | signal transduction |
BP | IBA | GO:0007275 | multicellular organism development |
BP | ISS | GO:0007283 | spermatogenesis |
BP | TAS | GO:0007283 | spermatogenesis |
BP | IEA | GO:0007286 | spermatid development |
BP | IEA | GO:0008284 | positive regulation of cell proliferation |
BP | IEA | GO:0008354 | germ cell migration |
BP | ISS | GO:0008360 | regulation of cell shape |
BP | IEA | GO:0008542 | visual learning |
BP | IEP | GO:0008584 | male gonad development |
BP | IBA | GO:0009968 | negative regulation of signal transduction |
BP | IEA | GO:0010628 | positive regulation of gene expression |
BP | TAS | GO:0010863 | positive regulation of phospholipase C activity |
BP | TAS | GO:0014068 | positive regulation of phosphatidylinositol 3-kinase signaling |
BP | IDA | GO:0018108 | peptidyl-tyrosine phosphorylation |
BP | IDA | GO:0019221 | cytokine-mediated signaling pathway |
BP | TAS | GO:0019827 | stem cell population maintenance |
BP | ISS | GO:0030032 | lamellipodium assembly |
BP | TAS | GO:0030097 | hemopoiesis |
BP | IBA | GO:0030154 | cell differentiation |
BP | ISS | GO:0030217 | T cell differentiation |
BP | ISS | GO:0030218 | erythrocyte differentiation |
BP | ISS | GO:0030318 | melanocyte differentiation |
BP | TAS | GO:0030318 | melanocyte differentiation |
BP | IEA | GO:0030335 | positive regulation of cell migration |
BP | IEA | GO:0031274 | positive regulation of pseudopodium assembly |
BP | IDA | GO:0031532 | actin cytoskeleton reorganization |
BP | IDA | GO:0032762 | mast cell cytokine production |
BP | IBA | GO:0033674 | positive regulation of kinase activity |
BP | IEA | GO:0035019 | somatic stem cell population maintenance |
BP | ISS | GO:0035162 | embryonic hemopoiesis |
BP | IEA | GO:0035234 | ectopic germ cell programmed cell death |
BP | IEA | GO:0035701 | hematopoietic stem cell migration |
BP | ISS | GO:0035855 | megakaryocyte development |
BP | IDA | GO:0038093 | Fc receptor signaling pathway |
BP | IDA | GO:0038109 | Kit signaling pathway |
BP | ISS | GO:0038162 | erythropoietin-mediated signaling pathway |
BP | TAS | GO:0042127 | regulation of cell proliferation |
BP | IMP | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein |
BP | IBA | GO:0043066 | negative regulation of apoptotic process |
BP | IEA | GO:0043069 | negative regulation of programmed cell death |
BP | IMP | GO:0043303 | mast cell degranulation |
BP | IBA | GO:0043410 | positive regulation of MAPK cascade |
BP | IMP | GO:0043410 | positive regulation of MAPK cascade |
BP | ISS | GO:0043473 | pigmentation |
BP | TAS | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity |
BP | IEA | GO:0043586 | tongue development |
BP | IEA | GO:0045747 | positive regulation of Notch signaling pathway |
BP | IMP | GO:0046427 | positive regulation of JAK-STAT cascade |
BP | IEA | GO:0046686 | response to cadmium ion |
BP | IDA | GO:0046777 | protein autophosphorylation |
BP | IEA | GO:0046854 | phosphatidylinositol phosphorylation |
BP | IEA | GO:0048070 | regulation of developmental pigmentation |
BP | IEA | GO:0048103 | somatic stem cell division |
BP | IEA | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity |
BP | ISS | GO:0048565 | digestive tract development |
BP | ISS | GO:0048863 | stem cell differentiation |
BP | IEA | GO:0050673 | epithelial cell proliferation |
BP | ISS | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound |
BP | IMP | GO:0051091 | positive regulation of DNA-binding transcription factor activity |
BP | TAS | GO:0051897 | positive regulation of protein kinase B signaling |
BP | IDA | GO:0060326 | cell chemotaxis |
BP | ISS | GO:0060374 | mast cell differentiation |
BP | TAS | GO:0060374 | mast cell differentiation |
BP | IBA | GO:0070374 | positive regulation of ERK1 and ERK2 cascade |
BP | TAS | GO:0070662 | mast cell proliferation |
BP | IEA | GO:0097067 | cellular response to thyroid hormone stimulus |
BP | ISS | GO:0097324 | melanocyte migration |
BP | ISS | GO:0097326 | melanocyte adhesion |
BP | IEA | GO:0120072 | positive regulation of pyloric antrum smooth muscle contraction |
BP | IEA | GO:1904251 | regulation of bile acid metabolic process |
BP | IEA | GO:1904343 | positive regulation of colon smooth muscle contraction |
BP | IEA | GO:1904349 | positive regulation of small intestine smooth muscle contraction |
BP | IDA | GO:1905065 | positive regulation of vascular smooth muscle cell differentiation |
CC | IEA | GO:0001669 | acrosomal vesicle |
CC | IDA | GO:0005615 | extracellular space |
CC | IBA | GO:0005737 | cytoplasm |
CC | IDA | GO:0005886 | plasma membrane |
CC | TAS | GO:0005886 | plasma membrane |
CC | IBA | GO:0005887 | integral component of plasma membrane |
CC | IEA | GO:0005911 | cell-cell junction |
CC | IEA | GO:0009897 | external side of plasma membrane |
CC | IEA | GO:0009898 | cytoplasmic side of plasma membrane |
CC | IEA | GO:0016021 | integral component of membrane |
CC | IEA | GO:0042629 | mast cell granule |
CC | IBA | GO:0043235 | receptor complex |
MF | IEA | GO:0002020 | protease binding |
MF | IBA | GO:0004709 | MAP kinase kinase kinase activity |
MF | IBA | GO:0004713 | protein tyrosine kinase activity |
MF | TAS | GO:0004713 | protein tyrosine kinase activity |
MF | IBA | GO:0004714 | transmembrane receptor protein tyrosine kinase activity |
MF | IDA | GO:0004714 | transmembrane receptor protein tyrosine kinase activity |
MF | IBA | GO:0004888 | transmembrane signaling receptor activity |
MF | IEA | GO:0005020 | stem cell factor receptor activity |
MF | TAS | GO:0005088 | Ras guanyl-nucleotide exchange factor activity |
MF | IPI | GO:0005515 | protein binding |
MF | IEA | GO:0005524 | ATP binding |
MF | IBA | GO:0019838 | growth factor binding |
MF | IDA | GO:0019955 | cytokine binding |
MF | IBA | GO:0031434 | mitogen-activated protein kinase kinase binding |
MF | IPI | GO:0042803 | protein homodimerization activity |
MF | IEA | GO:0046872 | metal ion binding |
MF | TAS | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity |
Gene expression in normal tissue: KIT
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in KIT
Database | Pathway ID | Pathway Des. |
---|---|---|
pid | cmyb_pathway | C-MYB transcription factor network |
pid | kitpathway | Signaling events mediated by Stem cell factor receptor (c-Kit) |
pharmgkb | PA164713427 | Imatinib Pathway, Pharmacokinetics/Pharmacodynamics |
pharmgkb | PA165959425 | Pathway_PA165959425 |
pharmgkb | PA165959584 | Sorafenib Pharmacodynamics |
netpath | Pathway_EGFR1 | EGFR1 |
netpath | Pathway_Gastrin | Gastrin |
netpath | Pathway_KitReceptor | KitReceptor |
kegg | hsa04010 | MAPK signaling pathway - Homo sapiens (human) |
kegg | hsa04014 | Ras signaling pathway - Homo sapiens (human) |
kegg | hsa04015 | Rap1 signaling pathway - Homo sapiens (human) |
kegg | hsa04060 | Cytokine-cytokine receptor interaction - Homo sapiens (human) |
kegg | hsa04072 | Phospholipase D signaling pathway - Homo sapiens (human) |
kegg | hsa04151 | PI3K-Akt signaling pathway - Homo sapiens (human) |
kegg | hsa04640 | Hematopoietic cell lineage - Homo sapiens (human) |
kegg | hsa04916 | Melanogenesis - Homo sapiens (human) |
kegg | hsa05200 | Pathways in cancer - Homo sapiens (human) |
kegg | hsa05221 | Acute myeloid leukemia - Homo sapiens (human) |
kegg | hsa05224 | Breast cancer - Homo sapiens (human) |
kegg | hsa05230 | Central carbon metabolism in cancer - Homo sapiens (human) |
wikipathways | WP2002 | miR-targeted genes in epithelium - TarBase |
wikipathways | WP2004 | miR-targeted genes in lymphocytes - TarBase |
wikipathways | WP2005 | miR-targeted genes in muscle cell - TarBase |
wikipathways | WP2406 | Cardiac Progenitor Differentiation |
wikipathways | WP2848 | Differentiation Pathway |
wikipathways | WP304 | Kit receptor signaling pathway |
wikipathways | WP3640 | Imatinib and Chronic Myeloid Leukemia |
wikipathways | WP3932 | Focal Adhesion-PI3K-Akt-mTOR-signaling pathway |
wikipathways | WP4086 | Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors |
wikipathways | WP4172 | PI3K-Akt Signaling Pathway |
wikipathways | WP4223 | Ras Signaling |
reactome | R-HSA-1257604 | PIP3 activates AKT signaling |
reactome | R-HSA-1433557 | Signaling by SCF-KIT |
reactome | R-HSA-1433557 | Signaling by SCF-KIT |
reactome | R-HSA-1433559 | Regulation of KIT signaling |
reactome | R-HSA-1433559 | Regulation of KIT signaling |
reactome | R-HSA-162582 | Signal Transduction |
reactome | R-HSA-162582 | Signal Transduction |
reactome | R-HSA-1643685 | Disease |
reactome | R-HSA-199418 | Negative regulation of the PI3K/AKT network |
reactome | R-HSA-212436 | Generic Transcription Pathway |
reactome | R-HSA-2219528 | PI3K/AKT Signaling in Cancer |
reactome | R-HSA-2219530 | Constitutive Signaling by Aberrant PI3K in Cancer |
reactome | R-HSA-5663202 | Diseases of signal transduction |
reactome | R-HSA-5673001 | RAF/MAP kinase cascade |
reactome | R-HSA-5683057 | MAPK family signaling cascades |
reactome | R-HSA-5684996 | MAPK1/MAPK3 signaling |
reactome | R-HSA-6811558 | PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling |
reactome | R-HSA-73857 | RNA Polymerase II Transcription |
reactome | R-HSA-74160 | Gene expression (Transcription) |
reactome | R-HSA-8864260 | Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors |
reactome | R-HSA-8866910 | TFAP2 (AP-2) family regulates transcription of growth factors and their receptors |
reactome | R-HSA-9006925 | Intracellular signaling by second messengers |
reactome | R-HSA-9006934 | Signaling by Receptor Tyrosine Kinases |
reactome | R-HSA-9006934 | Signaling by Receptor Tyrosine Kinases |
biocarta | badpathway | regulation of bad phosphorylation |
biocarta | melanocytepathway | melanocyte development and pigmentation pathway |
Gene-Drug: Aster Plot
Drug ID | Drug Name | Model Num. |
---|---|---|
iGMDRD193 | Fqi1 | 3 |
iGMDRD152 | 179324-69-7 | 4 |
iGMDRD61 | Kinetin riboside | 2 |
iGMDRD446 | LY 2183240 | 1 |
iGMDRD280 | CYTOCHALASIN B | 3 |
iGMDRD394 | BX-795 | 1 |
iGMDRD679 | Bistramide A | 1 |
iGMDRD466 | Chaetocin | 3 |
iGMDRD579 | PF750 | 3 |
iGMDRD599 | Salermide | 1 |
iGMDRD313 | Axitinib | 1 |
iGMDRD126 | Tipifarnib | 5 |
iGMDRD354 | Midostaurin | 1 |
iGMDRD239 | Dasatinib | 41 |
iGMDRD670 | ML 210 | 2 |
iGMDRD144 | NSC95397 | 2 |
iGMDRD399 | Selumetinib | 1 |
iGMDRD100 | Zebularine | 1 |
iGMDRD451 | Serdemetan | 1 |
iGMDRD41 | Imatinib | 385 |
iGMDRD190 | Nilotinib | 60 |
iGMDRD64 | Parbendazole | 3 |
iGMDRD134 | Sorafenib | 51 |
iGMDRD422 | Regorafenib | 60 |
iGMDRD920 | HSP90 inhibitor | 5 |
iGMDRD138 | PX 12 | 6 |
iGMDRD270 | Ciclosporin | 3 |
iGMDRD52 | Rotenone | 3 |
iGMDRD870 | BRD63610 | 1 |
iGMDRD187 | BRD9876 | 2 |
iGMDRD801 | 2,4-dideoxy-DC-45-A2 | 5 |
iGMDRD441 | TW 37 | 1 |
iGMDRD57 | Chloropentafluorobenzene | 3 |
iGMDRD314 | Tanespimycin | 2 |
iGMDRD341 | Triacsin c | 2 |
iGMDRD945 | ML214 | 6 |
iGMDRD883 | CIL55A | 4 |
iGMDRD123 | Isoevodiamine | 1 |
iGMDRD901 | ELCPK | 1 |
iGMDRD211 | (1S,3R)-RSL3 | 3 |
iGMDRD512 | nutlin 3 | 3 |
iGMDRD48 | Dexamethasone | 4 |
iGMDRD520 | Pictilisib | 1 |
iGMDRD456 | Crizotinib | 1 |
iGMDRD150 | RITA | 5 |
iGMDRD116 | CD437 | 2 |
iGMDRD872 | BRD7137 | 4 |
iGMDRD322 | FK 866 | 3 |
iGMDRD246 | NPC26 | 3 |
iGMDRD467 | Motesanib | 1 |
iGMDRD121 | GMX1778 | 4 |
iGMDRD251 | ML162 | 2 |
iGMDRD137 | Indisulam | 9 |
iGMDRD551 | Ponatinib | 8 |
iGMDRD241 | Sunitinib | 159 |
iGMDRD705 | Nakiterpiosin | 3 |
iGMDRD289 | Parthenolide | 3 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in KIT